Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor.
García-Valverde A, Rosell J, Sayols S, Gómez-Peregrina D, Pilco-Janeta DF, Olivares-Rivas I, de Álava E, Maurel J, Rubió-Casadevall J, Esteve A, Gut M, Valverde C, Barretina J, Carles J, Demetri GD, Fletcher JA, Arribas J, Serrano C. García-Valverde A, et al. Among authors: valverde c. Oncogene. 2021 Dec;40(48):6614-6626. doi: 10.1038/s41388-021-02049-0. Epub 2021 Oct 7. Oncogene. 2021. PMID: 34621020
Acute severe hypothyroidism induced by sunitinib.
Prat A, Serrano C, Valverde C, Calvo E. Prat A, et al. Among authors: valverde c. Radiother Oncol. 2008 Oct;89(1):124-5. doi: 10.1016/j.radonc.2008.05.007. Epub 2008 May 24. Radiother Oncol. 2008. PMID: 18502526 No abstract available.
Molecular basis for the treatment of renal cell carcinoma.
Suárez C, Morales R, Muñoz E, Rodón J, Valverde CM, Carles J. Suárez C, et al. Among authors: valverde cm. Clin Transl Oncol. 2010 Jan;12(1):15-21. doi: 10.1007/s12094-010-0461-4. Clin Transl Oncol. 2010. PMID: 20080466 Review.
Bilateral testicular germ cell tumours: a single hospital experience.
Morales-Barrera R, Valverde C, Rodón J, Pérez J, Maldonado X, Suárez C, Trilla E, Carles J. Morales-Barrera R, et al. Among authors: valverde c. Clin Transl Oncol. 2010 Apr;12(4):299-302. doi: 10.1007/s12094-010-0507-7. Clin Transl Oncol. 2010. PMID: 20462840
Emerging therapies for urothelial cancer.
Serrano C, Morales R, Suárez C, Núñez I, Valverde C, Rodón J, Humbert J, Padrós O, Carles J. Serrano C, et al. Among authors: valverde c. Cancer Treat Rev. 2012 Jun;38(4):311-7. doi: 10.1016/j.ctrv.2011.10.007. Epub 2011 Nov 22. Cancer Treat Rev. 2012. PMID: 22113129 Review.
BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours.
Serrano C, Simonetti S, Hernández-Losa J, Valverde C, Carrato C, Bagué S, Orellana R, Somoza R, Moliné T, Carles J, Huguet P, Romagosa C, Ramón y Cajal S. Serrano C, et al. Among authors: valverde c. Histopathology. 2013 Feb;62(3):499-504. doi: 10.1111/his.12021. Epub 2012 Nov 27. Histopathology. 2013. PMID: 23190154
Role of immunotherapy in castration-resistant prostate cancer (CRPC).
Suárez C, Morales-Barrera R, Ramos V, Núñez I, Valverde C, Planas J, Morote J, Maldonado X, Carles J. Suárez C, et al. Among authors: valverde c. BJU Int. 2014 Mar;113(3):367-75. doi: 10.1111/bju.12110. Epub 2013 Apr 12. BJU Int. 2014. PMID: 23650874 Review.
300 results